EUVIMEDEUVIMED entdecken
Crossref

Botulinum toxin type a treatment for Meige syndrome A case of blepharospasm combined with oromandibular dystonia and literature review

Xiao Long

Annals of Case Reports and Medical Images · 31.12.2025 · 2 (2)

DOI: 10.52768/3065-7849/1049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Case Reports and Medical Images, online erschienen am 31.12.2025. Verfasst von Xiao Long.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Meige Syndrome (MS) is characterized by blepharospasm and oromandibular dystonia that are often refractory to oral medications.

Zitieren

APA

Long, X. (2025). Botulinum toxin type a treatment for Meige syndrome A case of blepharospasm combined with oromandibular dystonia and literature review. Annals of Case Reports and Medical Images, 2(2). https://doi.org/10.52768/3065-7849/1049

Vancouver

Long X. Botulinum toxin type a treatment for Meige syndrome A case of blepharospasm combined with oromandibular dystonia and literature review. Annals of Case Reports and Medical Images. 2025;2(2). doi:10.52768/3065-7849/1049

BibTeX
@article{Long2025,
  author = {Long, Xiao},
  title = {Botulinum toxin type a treatment for Meige syndrome A case of blepharospasm combined with oromandibular dystonia and literature review},
  journal = {Annals of Case Reports and Medical Images},
  year = {2025},
  volume = {2},
  number = {2},
  doi = {10.52768/3065-7849/1049}
}
Kostenlos starten →